A new study has been taken out by a group of researchers from Stanford University School of Medicine. As per the study, a new vaccine has been developed to tackle type-1 diabetes.
The novel vaccine works by stopping the negative immune response of the type-1 diabetes. Researcher Dr. Lawrence Steinman, Professor of pediatrics and of neurology and neurological sciences, in the university, said that they have come up with a new concept of medicine.
"This vaccine is a new concept. It's shutting off a specific immune response, rather than turning on specific immune responses as conventional vaccines for, say, influenza or polio aim to do", said Dr. Steinman.
The research findings have been published in the journal Science Transitional Medicine. In total, 80 participants diagnosed with type-1 diabetes were enrolled. Five sub-groups were made and four of them received different dosages of the new vaccine. The last group that is the fifth group received placebo injection.
It is said that those who will take the novel vaccine are also at reduced risk to see destruction of beta cells. Dr. Steinman has said that larger clinical trial is required that should continue for a longer time. He also added that the vaccine can be a game changer for the treatment of type-1 diabetes.